Early Detection of Kidney Damage in Sickle Cell Children
This study tests whether certain urine markers and a special MRI can detect early kidney damage in children with sickle cell disease. Participation may help identify kidney problems sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is under 18 years of age.
- Has a confirmed diagnosis of sickle cell disease.
- Condition is stable at enrollment (no acute crisis or illness).
- No known kidney disease unrelated to sickle cell.
- No diabetes, hypertension, or use of nephrotoxic medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
This study tests two new methods to measure how well your kidneys can handle extra work, called kidney reserve. It might help find early signs of kidney problems in people with sickle cell disease or those who have donated a kidney.
This study looks at how major organs like the brain, kidneys, heart, and liver are affected in adults with sickle cell disease, whether they've had a bone marrow transplant or gene therapy, or are continuing regular treatment. You'll get detailed tests that can help doctors understand the disease better, which may lead to improved care.
This study tests whether empagliflozin, a medicine that protects the kidneys in people with diabetes, can also protect the kidneys in people with sickle cell disease. The goal is to see if it can reduce protein in the urine, which is a sign of kidney stress.
This trial tests a way to use hydroxyurea more safely and effectively in children with sickle cell anemia. It may help doctors fine-tune dosing to reduce complications and side effects.
This trial checks whether monitoring hydroxyurea drug levels in the blood can help doctors find the best dose for sickle cell patients. It focuses on people with HbSS who have recently had a pain crisis or whose current dose isn't working.
Hear when a new Sickle Cell Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.